Nikola Announces Extension of Exchange Offer to Acquire Romeo Power Common Stock
/PRNewswire/ -- Nikola Corporation (Nasdaq: NKLA) ("Nikola"), a provider of zero-emissions transportation and energy infrastructure solutions, today announced...
Stay updated with breaking news from Recommendation Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Nikola Corporation (Nasdaq: NKLA) ("Nikola"), a provider of zero-emissions transportation and energy infrastructure solutions, today announced...
Romeo stockholders should contact Alliance Advisors for assistance by calling toll-free at (855) 643-7453 or by emailing nkla@allianceadvisors.com...
Once considered a disease of aging, type 2 diabetes is now observed at increasing rates in young people. The prevalence of type 2 diabetes in children and adol
Investegate announcements from Novo Nordisk A/S, Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders
Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for $20 per